User profiles for Daniel G. Stover
Daniel G. StoverOhio State University Comprehensive Cancer Center Verified email at osumc.edu Cited by 9324 |
[HTML][HTML] Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Whole-exome sequencing of cell-free DNA (cfDNA) could enable comprehensive profiling
of tumors from blood but the genome-wide concordance between cfDNA and tumor biopsies …
of tumors from blood but the genome-wide concordance between cfDNA and tumor biopsies …
[PDF][PDF] Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies
We comprehensively analyzed clinical, genomic, and transcriptomic data of a cohort of 465
primary triple-negative breast cancer (TNBC). PIK3CA mutations and copy-number gains of …
primary triple-negative breast cancer (TNBC). PIK3CA mutations and copy-number gains of …
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous and clinically aggressive disease
for which there is no targeted therapy 1 , 2 , 3 . BET bromodomain inhibitors, which have …
for which there is no targeted therapy 1 , 2 , 3 . BET bromodomain inhibitors, which have …
[HTML][HTML] CDK7-dependent transcriptional addiction in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer that
exhibits extremely high levels of genetic complexity and yet a relatively uniform transcriptional …
exhibits extremely high levels of genetic complexity and yet a relatively uniform transcriptional …
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
Neoplastic cells within individual carcinomas often exhibit considerable phenotypic heterogeneity
in their epithelial versus mesenchymal-like cell states. Because carcinoma cells with …
in their epithelial versus mesenchymal-like cell states. Because carcinoma cells with …
[HTML][HTML] Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
…, J Ding, X Zhu, J Zou, C Verschraegen, DG Stover… - Cell research, 2021 - nature.com
Triple-negative breast cancer (TNBC) is a highly heterogeneous disease, and molecular
subtyping may result in improved diagnostic precision and targeted therapies. Our previous …
subtyping may result in improved diagnostic precision and targeted therapies. Our previous …
[PDF][PDF] CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA wild-type and mutated models of triple-negative breast cancer
Although poly(ADP-ribose) polymerase (PARP) inhibitors are active in homologous recombination
(HR)-deficient cancers, their utility is limited by acquired resistance after restoration of …
(HR)-deficient cancers, their utility is limited by acquired resistance after restoration of …
[PDF][PDF] Cancer cells co-opt the neuronal redox-sensing channel TRPA1 to promote oxidative-stress tolerance
Cancer cell survival is dependent on oxidative-stress defenses against reactive oxygen species
(ROS) that accumulate during tumorigenesis. Here, we show a non-canonical oxidative-…
(ROS) that accumulate during tumorigenesis. Here, we show a non-canonical oxidative-…
[HTML][HTML] Association of cell-free DNA tumor fraction and somatic copy number alterations with survival in metastatic triple-negative breast cancer
Purpose Cell-free DNA (cfDNA) offers the potential for minimally invasive genome-wide profiling
of tumor alterations without tumor biopsy and may be associated with patient prognosis. …
of tumor alterations without tumor biopsy and may be associated with patient prognosis. …
Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer
Purpose: Existing cell-free DNA (cfDNA) methods lack the sensitivity needed for detecting
minimal residual disease (MRD) following therapy. We developed a test for tracking hundreds …
minimal residual disease (MRD) following therapy. We developed a test for tracking hundreds …